Patient satisfaction with subcutaneous versus intravenous ocrelizumab administration in multiple sclerosis: a cross-sectional study. // Multiple Sclerosis and Related Disorders. – URL: https://www.sciencedirect.com/science/article/pii/S2211034826010849?dgcid=rss_sd_all
Patient satisfaction with subcutaneous versus intravenous ocrelizumab administration in multiple sclerosis: a cross-sectional study. Multiple Sclerosis and Related Disorders. https://www.sciencedirect.com/science/article/pii/S2211034826010849?dgcid=rss_sd_all
“Patient satisfaction with subcutaneous versus intravenous ocrelizumab administration in multiple sclerosis: a cross-sectional study.” Multiple Sclerosis and Related Disorders.
@article{article9031,
title = {Patient satisfaction with subcutaneous versus intravenous ocrelizumab administration in multiple sclerosis: a cross-sectional study},
journal = {Multiple Sclerosis and Related Disorders},
url = {https://www.sciencedirect.com/science/article/pii/S2211034826010849?dgcid=rss_sd_all}
}